Kapidex dexlansoprazole: Post-marketing study data

A 4-week, double-blind post-marketing trial in 305 patients showed that 30 mg Kapidex delayed-release capsules led to a significantly greater percentage of heartburn-free nights vs. placebo (73% vs. 3...